Approval of 2025 financial statements
The first section has been approved and a favourable opinion has been given on the second section of the Remuneration Report
Approval of plan for purchase and disposal of the Company’s ordinary shares
Milan, 5 May 2026 - The Ordinary General Meeting of Shareholders of Immsi S.p.A. met today, in second call, chaired by Matteo Colaninno, with 60.254% of the share capital present.
The Shareholders’ Meeting examined and approved unanimously the 2025 Annual Financial Statements of Immsi S.p.A., and took note of the Immsi Group’s consolidated Financial Statements as at 31 December 2025 and the consolidated sustainability report as at 31 December 2025.
In summary, in the 2025 financial year, the Immsi Group’s consolidated turnover stood at €1,592.8 million, with an EBITDA of €252.9 million and an EBITDA margin of 15.9%, the highest ever recorded. Net profit was 10.7 million euro including minority interests of 10.6 million euro. Immsi Group net financial debt at 31 December 2025 was 986.6 million euro. Immsi Group capital expenditure in 2025 amounted to 158.2 million euro.
The Shareholders’ Meeting resolved to cover the loss for the financial year, amounting to €21,983,817.51, by utilising the available retained earnings and, for the remaining amount, the share premium reserve.
The General Meeting of Immsi S.p.A. also approved the remuneration policy set out in Section I of the “Report on remuneration policy and remuneration paid” and expressed its approval of Section II of the same Report.
The Immsi S.p.A. Shareholders’ Meeting also renewed the authorisation for the purchase and disposal of the Company’s own shares. The purpose is to provide the Company with a useful strategic investment opportunity for the purposes allowed under law, including the purposes contemplated in art. 5 of Regulation (EU) 596/2014 (Market Abuse Regulation, hereinafter “MAR”) and in compliance with the practices allowed under art. 13 MAR and the related measures adopted by the national authority, and also for purchases of own shares for subsequent cancellation.
The share buyback authorisation was granted for a maximum number of shares that, taking into account the Immsi S.p.A. ordinary shares held from time to time by the company and the subsidiaries, may not exceed the maximum limit established by the applicable laws in force at the time, and for a consideration that does not exceed the greater of the price of the most recent independent transaction and the price of the highest current independent offer on the trading markets where the buyback is made, subject to the condition that the per-share purchase consideration shall not in any case be more than 20% below and 10% above the mean official share price in the 10 trading days before each purchase transaction.
The purchase authorisation will remain in effect for 18 months as from the date of the AGM, while the authorisation for disposal was granted without any time limit.
As of today, the company does not hold any own shares.
For further information regarding the resolutions passed at today’s Shareholders’ Meeting, please refer to the relevant explanatory reports available on the Company’s website (Governance/Shareholders’ Meeting/Archive/2026) and to the minutes of the meeting, which will be published in accordance with the terms and procedures laid down by law.